Vaccination

Medicago and GSK to begin final Covid-19 vaccine trials

Canada's Medicago and British pharmaceutical giant GlaxoSmithKline (GSK) announced Thursday the launch of phase 2 and 3 clinical trials on a COVID-19 vaccine, one of a series of candidates being developed worldwide.

Vaccination

Sanofi and GSK to provide 72 million vaccine doses to Canada

French pharmaceutical firm Sanofi and Britain's GSK have promised up to 72 million doses of their COVID-19 vaccine candidate to the Canadian government, which has already signed similar agreements with several American companies.

Other

EU greenlights GSK-Pfizer joint venture

The EU on Wednesday approved the merger of the consumer healthcare activities of pharmaceutical giants GlaxoSmithKline and Pfizer that produce over-the-counter medicines.

Medical economics

GSK, Pfizer to merge consumer healthcare units

Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.

Other

GSK sells health drinks arm, buys US cancer treatment firm

British pharmaceutical group GlaxoSmithKline announced two multi-billion-dollar deals Monday—the sale of its Asian health drinks unit to Anglo-Dutch food giant Unilever and the purchase of US cancer specialist Tesaro.

Medications

GlaxoSmithKline opts to hold on to HIV business

British-based drugmaker GlaxoSmithKline opted Wednesday to keep its stake in its stand-alone HIV business as it set out its strategy following a big deal with Switzerland's Novartis.

Other

France's Sanofi opens research hub in China

French pharmaceutical giant Sanofi opened a research hub in Shanghai Thursday, the company said, as foreign drug firms face government scrutiny after drugmaker GlaxoSmithKline (GSK) was found guilty of bribery last week.

page 5 from 8